> top > docs > PubMed:16506214 > annotations

PubMed:16506214 JSONTXT

Annnotations TAB JSON ListView MergeView

Inflammaging

Id Subject Object Predicate Lexical cue
T1 0-82 Sentence denotes Genetic variation in the COX-2 gene and the association with prostate cancer risk.
T2 83-161 Sentence denotes COX-2 is a key enzyme in the conversion of arachidonic acid to prostaglandins.
T3 162-279 Sentence denotes The prostaglandins produced by COX-2 are involved in inflammation and pain response in different tissues in the body.
T4 280-496 Sentence denotes Accumulating evidence from epidemiologic studies, chemical carcinogen-induced rodent models and clinical trials indicate that COX-2 plays a role in human carcinogenesis and is overexpressed in prostate cancer tissue.
T5 497-594 Sentence denotes We examined whether sequence variants in the COX-2 gene are associated with prostate cancer risk.
T6 595-728 Sentence denotes We analyzed a large population-based case-control study, cancer prostate in Sweden (CAPS) consisting of 1,378 cases and 782 controls.
T7 729-851 Sentence denotes We evaluated 16 single nucleotide polymorphisms (SNPs) spanning the entire COX-2 gene in 94 subjects of the control group.
T8 852-1044 Sentence denotes Five SNPs had a minor allele frequency of more than 5% in our study population and these were genotyped in all case patients and control subjects and gene-specific haplotypes were constructed.
T9 1045-1276 Sentence denotes A statistically significant difference in allele frequency between cases and controls was observed for 2 of the SNPs (+3100 T/G and +8365 C/T), with an odds ratio of 0.78 (95% CI=0.64-0.96) and 0.65 (95% CI=0.45-0.94) respectively.
T10 1277-1529 Sentence denotes In the haplotype analysis, 1 haplotype carrying the variant allele from both +3100 T/G and +8365 C/T, with a population frequency of 3%, was also significantly associated with decreased risk of prostate cancer (p=0.036, global simulated p-value=0.046).
T11 1530-1710 Sentence denotes This study supports the hypothesis that inflammation is involved in prostate carcinogenesis and that sequence variation within the COX-2 gene influence the risk of prostate cancer.
T1 0-82 Sentence denotes Genetic variation in the COX-2 gene and the association with prostate cancer risk.
T2 83-161 Sentence denotes COX-2 is a key enzyme in the conversion of arachidonic acid to prostaglandins.
T3 162-279 Sentence denotes The prostaglandins produced by COX-2 are involved in inflammation and pain response in different tissues in the body.
T4 280-496 Sentence denotes Accumulating evidence from epidemiologic studies, chemical carcinogen-induced rodent models and clinical trials indicate that COX-2 plays a role in human carcinogenesis and is overexpressed in prostate cancer tissue.
T5 497-594 Sentence denotes We examined whether sequence variants in the COX-2 gene are associated with prostate cancer risk.
T6 595-728 Sentence denotes We analyzed a large population-based case-control study, cancer prostate in Sweden (CAPS) consisting of 1,378 cases and 782 controls.
T7 729-851 Sentence denotes We evaluated 16 single nucleotide polymorphisms (SNPs) spanning the entire COX-2 gene in 94 subjects of the control group.
T8 852-1044 Sentence denotes Five SNPs had a minor allele frequency of more than 5% in our study population and these were genotyped in all case patients and control subjects and gene-specific haplotypes were constructed.
T9 1045-1276 Sentence denotes A statistically significant difference in allele frequency between cases and controls was observed for 2 of the SNPs (+3100 T/G and +8365 C/T), with an odds ratio of 0.78 (95% CI=0.64-0.96) and 0.65 (95% CI=0.45-0.94) respectively.
T10 1277-1529 Sentence denotes In the haplotype analysis, 1 haplotype carrying the variant allele from both +3100 T/G and +8365 C/T, with a population frequency of 3%, was also significantly associated with decreased risk of prostate cancer (p=0.036, global simulated p-value=0.046).
T11 1530-1710 Sentence denotes This study supports the hypothesis that inflammation is involved in prostate carcinogenesis and that sequence variation within the COX-2 gene influence the risk of prostate cancer.

LitCoin-entities-OrganismTaxon-PD

Id Subject Object Predicate Lexical cue db_id
T1 358-364 OrganismTaxon denotes rodent NCBItxid:9989
T2 428-433 OrganismTaxon denotes human NCBItxid:9606

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-82 Sentence denotes Genetic variation in the COX-2 gene and the association with prostate cancer risk.
T2 83-161 Sentence denotes COX-2 is a key enzyme in the conversion of arachidonic acid to prostaglandins.
T3 162-279 Sentence denotes The prostaglandins produced by COX-2 are involved in inflammation and pain response in different tissues in the body.
T4 280-496 Sentence denotes Accumulating evidence from epidemiologic studies, chemical carcinogen-induced rodent models and clinical trials indicate that COX-2 plays a role in human carcinogenesis and is overexpressed in prostate cancer tissue.
T5 497-594 Sentence denotes We examined whether sequence variants in the COX-2 gene are associated with prostate cancer risk.
T6 595-728 Sentence denotes We analyzed a large population-based case-control study, cancer prostate in Sweden (CAPS) consisting of 1,378 cases and 782 controls.
T7 729-851 Sentence denotes We evaluated 16 single nucleotide polymorphisms (SNPs) spanning the entire COX-2 gene in 94 subjects of the control group.
T8 852-1044 Sentence denotes Five SNPs had a minor allele frequency of more than 5% in our study population and these were genotyped in all case patients and control subjects and gene-specific haplotypes were constructed.
T9 1045-1276 Sentence denotes A statistically significant difference in allele frequency between cases and controls was observed for 2 of the SNPs (+3100 T/G and +8365 C/T), with an odds ratio of 0.78 (95% CI=0.64-0.96) and 0.65 (95% CI=0.45-0.94) respectively.
T10 1277-1529 Sentence denotes In the haplotype analysis, 1 haplotype carrying the variant allele from both +3100 T/G and +8365 C/T, with a population frequency of 3%, was also significantly associated with decreased risk of prostate cancer (p=0.036, global simulated p-value=0.046).
T11 1530-1710 Sentence denotes This study supports the hypothesis that inflammation is involved in prostate carcinogenesis and that sequence variation within the COX-2 gene influence the risk of prostate cancer.

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
2781 25-30 GeneOrGeneProduct denotes COX-2 NCBIGene:4513
2782 61-76 DiseaseOrPhenotypicFeature denotes prostate cancer MESH:D011471
2783 83-88 GeneOrGeneProduct denotes COX-2 NCBIGene:4513
2784 126-142 ChemicalEntity denotes arachidonic acid MESH:D016718
2785 146-160 ChemicalEntity denotes prostaglandins MESH:D011453
2786 166-180 ChemicalEntity denotes prostaglandins MESH:D011453
2787 193-198 GeneOrGeneProduct denotes COX-2 NCBIGene:4513
2788 215-227 DiseaseOrPhenotypicFeature denotes inflammation MESH:D007249
2789 232-236 DiseaseOrPhenotypicFeature denotes pain MESH:D010146
2790 406-411 GeneOrGeneProduct denotes COX-2 NCBIGene:4513
2791 428-433 OrganismTaxon denotes human NCBITaxon:9606
2792 434-448 DiseaseOrPhenotypicFeature denotes carcinogenesis MESH:D009369
2793 473-488 DiseaseOrPhenotypicFeature denotes prostate cancer MESH:D011471
2794 542-547 GeneOrGeneProduct denotes COX-2 NCBIGene:4513
2795 573-588 DiseaseOrPhenotypicFeature denotes prostate cancer MESH:D011471
2796 652-667 DiseaseOrPhenotypicFeature denotes cancer prostate MESH:D011471
2797 804-809 GeneOrGeneProduct denotes COX-2 NCBIGene:4513
2798 968-976 OrganismTaxon denotes patients NCBITaxon:9606
2799 1163-1172 SequenceVariant denotes +3100 T/G c|SUB|T|+3100|G
2800 1177-1186 SequenceVariant denotes +8365 C/T c|SUB|C|+8365|T
2801 1354-1363 SequenceVariant denotes +3100 T/G c|SUB|T|+3100|G
2802 1368-1377 SequenceVariant denotes +8365 C/T c|SUB|C|+8365|T
2803 1471-1486 DiseaseOrPhenotypicFeature denotes prostate cancer MESH:D011471
2804 1570-1582 DiseaseOrPhenotypicFeature denotes inflammation MESH:D007249
2805 1598-1621 DiseaseOrPhenotypicFeature denotes prostate carcinogenesis MESH:D011471
2806 1661-1666 GeneOrGeneProduct denotes COX-2 NCBIGene:4513
2807 1694-1709 DiseaseOrPhenotypicFeature denotes prostate cancer MESH:D011471

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 61-76 DiseaseOrPhenotypicFeature denotes prostate cancer 0008315
T2 70-76 DiseaseOrPhenotypicFeature denotes cancer 0004992
T3 473-488 DiseaseOrPhenotypicFeature denotes prostate cancer 0008315
T4 482-488 DiseaseOrPhenotypicFeature denotes cancer 0004992
T5 573-588 DiseaseOrPhenotypicFeature denotes prostate cancer 0008315
T6 582-588 DiseaseOrPhenotypicFeature denotes cancer 0004992
T7 652-658 DiseaseOrPhenotypicFeature denotes cancer 0004992
T8 659-667 DiseaseOrPhenotypicFeature denotes prostate 0005280
T9 1471-1486 DiseaseOrPhenotypicFeature denotes prostate cancer 0008315
T10 1480-1486 DiseaseOrPhenotypicFeature denotes cancer 0004992
T11 1598-1606 DiseaseOrPhenotypicFeature denotes prostate 0005280
T12 1694-1709 DiseaseOrPhenotypicFeature denotes prostate cancer 0008315
T13 1703-1709 DiseaseOrPhenotypicFeature denotes cancer 0004992

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 25-30 GeneOrGeneProduct denotes COX-2
T2 83-88 GeneOrGeneProduct denotes COX-2
T3 98-104 GeneOrGeneProduct denotes enzyme
T4 138-142 GeneOrGeneProduct denotes acid
T5 193-198 GeneOrGeneProduct denotes COX-2
T6 232-236 GeneOrGeneProduct denotes pain
T7 406-411 GeneOrGeneProduct denotes COX-2
T8 542-547 GeneOrGeneProduct denotes COX-2
T9 609-614 GeneOrGeneProduct denotes large
T10 679-683 GeneOrGeneProduct denotes CAPS
T11 804-809 GeneOrGeneProduct denotes COX-2
T12 868-873 GeneOrGeneProduct denotes minor
T13 881-890 GeneOrGeneProduct denotes frequency
T14 1094-1103 GeneOrGeneProduct denotes frequency
T15 1397-1406 GeneOrGeneProduct denotes frequency
T16 1661-1666 GeneOrGeneProduct denotes COX-2

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 25-30 GeneOrGeneProduct denotes COX-2
T2 83-88 GeneOrGeneProduct denotes COX-2
T3 98-104 GeneOrGeneProduct denotes enzyme
T4 138-142 GeneOrGeneProduct denotes acid
T5 193-198 GeneOrGeneProduct denotes COX-2
T6 232-236 GeneOrGeneProduct denotes pain
T7 350-357 GeneOrGeneProduct denotes induced
T8 406-411 GeneOrGeneProduct denotes COX-2
T9 542-547 GeneOrGeneProduct denotes COX-2
T10 609-614 GeneOrGeneProduct denotes large
T11 626-631 GeneOrGeneProduct denotes based
T12 632-636 GeneOrGeneProduct denotes case
T13 679-683 GeneOrGeneProduct denotes CAPS
T14 705-710 GeneOrGeneProduct denotes cases
T15 784-792 GeneOrGeneProduct denotes spanning
T16 797-803 GeneOrGeneProduct denotes entire
T17 804-809 GeneOrGeneProduct denotes COX-2
T18 862-867 GeneOrGeneProduct denotes had a
T19 868-873 GeneOrGeneProduct denotes minor
T20 881-890 GeneOrGeneProduct denotes frequency
T21 959-962 GeneOrGeneProduct denotes all
T22 963-967 GeneOrGeneProduct denotes case
T23 1094-1103 GeneOrGeneProduct denotes frequency
T24 1112-1117 GeneOrGeneProduct denotes cases
T25 1144-1152 GeneOrGeneProduct denotes for 2 of
T26 1397-1406 GeneOrGeneProduct denotes frequency
T27 1516-1521 GeneOrGeneProduct denotes value
T28 1661-1666 GeneOrGeneProduct denotes COX-2

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 61-76 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T2 215-227 DiseaseOrPhenotypicFeature denotes inflammation D007249
T3 232-236 DiseaseOrPhenotypicFeature denotes pain D010146
T4 434-448 DiseaseOrPhenotypicFeature denotes carcinogenesis D063646
T5 473-488 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T6 573-588 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T7 652-667 DiseaseOrPhenotypicFeature denotes cancer prostate D011471
T8 1471-1486 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T9 1570-1582 DiseaseOrPhenotypicFeature denotes inflammation D007249
T10 1607-1621 DiseaseOrPhenotypicFeature denotes carcinogenesis D063646
T11 1694-1709 DiseaseOrPhenotypicFeature denotes prostate cancer D011471

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 25-30 GeneOrGeneProduct denotes COX-2
T2 83-88 GeneOrGeneProduct denotes COX-2
T3 193-198 GeneOrGeneProduct denotes COX-2
T4 406-411 GeneOrGeneProduct denotes COX-2
T5 542-547 GeneOrGeneProduct denotes COX-2
T6 679-683 GeneOrGeneProduct denotes CAPS
T7 804-809 GeneOrGeneProduct denotes COX-2
T8 1661-1666 GeneOrGeneProduct denotes COX-2

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 61-76 DiseaseOrPhenotypicFeature denotes prostate cancer 0008315
T2 473-488 DiseaseOrPhenotypicFeature denotes prostate cancer 0008315
T3 573-588 DiseaseOrPhenotypicFeature denotes prostate cancer 0008315
T4 1471-1486 DiseaseOrPhenotypicFeature denotes prostate cancer 0008315
T5 1694-1709 DiseaseOrPhenotypicFeature denotes prostate cancer 0008315

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 61-76 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T2 215-227 DiseaseOrPhenotypicFeature denotes inflammation DISEASE|D007249
T4 232-236 DiseaseOrPhenotypicFeature denotes pain D010146
T5 339-349 DiseaseOrPhenotypicFeature denotes carcinogen DISEASE
T6 434-448 DiseaseOrPhenotypicFeature denotes carcinogenesis D063646
T7 473-488 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T8 573-588 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T9 652-667 DiseaseOrPhenotypicFeature denotes cancer prostate D011471
T10 1471-1486 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T11 1570-1582 DiseaseOrPhenotypicFeature denotes inflammation DISEASE|D007249
T13 1607-1621 DiseaseOrPhenotypicFeature denotes carcinogenesis D063646
T14 1694-1709 DiseaseOrPhenotypicFeature denotes prostate cancer D011471

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 61-76 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T2 215-227 DiseaseOrPhenotypicFeature denotes inflammation D007249
T3 232-236 DiseaseOrPhenotypicFeature denotes pain D010146
T4 339-349 DiseaseOrPhenotypicFeature denotes carcinogen DISEASE
T5 434-448 DiseaseOrPhenotypicFeature denotes carcinogenesis D063646
T6 473-488 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T7 573-588 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T8 652-667 DiseaseOrPhenotypicFeature denotes cancer prostate D011471
T9 1471-1486 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T10 1570-1582 DiseaseOrPhenotypicFeature denotes inflammation D007249
T11 1607-1621 DiseaseOrPhenotypicFeature denotes carcinogenesis D063646
T12 1694-1709 DiseaseOrPhenotypicFeature denotes prostate cancer D011471

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 358-364 OrganismTaxon denotes rodent
T2 428-433 OrganismTaxon denotes human
T3 968-976 OrganismTaxon denotes patients

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 126-142 ChemicalEntity denotes arachidonic acid D016718|http://purl.obolibrary.org/obo/CHEBI_15843
T3 146-160 ChemicalEntity denotes prostaglandins D011453|http://purl.obolibrary.org/obo/CHEBI_26333
T5 166-180 ChemicalEntity denotes prostaglandins D011453|http://purl.obolibrary.org/obo/CHEBI_26333

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T5 166-180 ChemicalEntity denotes prostaglandins http://purl.obolibrary.org/obo/CHEBI_26333|D011453
T3 146-160 ChemicalEntity denotes prostaglandins http://purl.obolibrary.org/obo/CHEBI_26333|D011453
T1 126-142 ChemicalEntity denotes arachidonic acid http://purl.obolibrary.org/obo/CHEBI_15843|D016718
T8 1661-1666 GeneOrGeneProduct denotes COX-2
T7 804-809 GeneOrGeneProduct denotes COX-2
T6 679-683 GeneOrGeneProduct denotes CAPS
T77211 542-547 GeneOrGeneProduct denotes COX-2
T4 406-411 GeneOrGeneProduct denotes COX-2
T81885 193-198 GeneOrGeneProduct denotes COX-2
T2 83-88 GeneOrGeneProduct denotes COX-2
T46297 25-30 GeneOrGeneProduct denotes COX-2
T12 1694-1709 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T11 1607-1621 DiseaseOrPhenotypicFeature denotes carcinogenesis D063646
T10 1570-1582 DiseaseOrPhenotypicFeature denotes inflammation D007249
T9 1471-1486 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T8871 652-667 DiseaseOrPhenotypicFeature denotes cancer prostate D011471
T38855 573-588 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T56134 473-488 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T79739 434-448 DiseaseOrPhenotypicFeature denotes carcinogenesis D063646
T26490 339-349 DiseaseOrPhenotypicFeature denotes carcinogen DISEASE
T68966 232-236 DiseaseOrPhenotypicFeature denotes pain D010146
T39801 215-227 DiseaseOrPhenotypicFeature denotes inflammation D007249
T89685 61-76 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T89142 968-976 OrganismTaxon denotes patients
T91635 428-433 OrganismTaxon denotes human
T71974 358-364 OrganismTaxon denotes rodent

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 232-236 HP_0012531 denotes pain
T2 473-488 HP_0012125 denotes prostate cancer
T3 482-488 HP_0002664 denotes cancer
T4 573-588 HP_0012125 denotes prostate cancer
T5 582-588 HP_0002664 denotes cancer
T6 652-667 HP_0012125 denotes cancer prostate
T7 652-658 HP_0002664 denotes cancer
T8 1471-1486 HP_0012125 denotes prostate cancer
T9 1480-1486 HP_0002664 denotes cancer
T10 1586-1606 HP_0008775 denotes involved in prostate
T11 1694-1709 HP_0012125 denotes prostate cancer
T12 1703-1709 HP_0002664 denotes cancer

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
16506214-0#25#30#gene4513 25-30 gene4513 denotes COX-2
16506214-0#25#30#gene5743 25-30 gene5743 denotes COX-2
16506214-0#61#76#diseaseC0376358 61-76 diseaseC0376358 denotes prostate cancer
16506214-0#61#76#diseaseC0600139 61-76 diseaseC0600139 denotes prostate cancer
16506214-0#61#76#diseaseC0376358 61-76 diseaseC0376358 denotes prostate cancer
16506214-0#61#76#diseaseC0600139 61-76 diseaseC0600139 denotes prostate cancer
16506214-10#131#136#gene4513 1661-1666 gene4513 denotes COX-2
16506214-10#131#136#gene5743 1661-1666 gene5743 denotes COX-2
16506214-10#77#91#diseaseC0596263 1607-1621 diseaseC0596263 denotes carcinogenesis
16506214-2#31#36#gene4513 193-198 gene4513 denotes COX-2
16506214-2#31#36#gene5743 193-198 gene5743 denotes COX-2
16506214-2#70#74#diseaseC0030193 232-236 diseaseC0030193 denotes pain
25#30#gene451361#76#diseaseC0376358 16506214-0#25#30#gene4513 16506214-0#61#76#diseaseC0376358 associated_with COX-2,prostate cancer
25#30#gene451361#76#diseaseC0600139 16506214-0#25#30#gene4513 16506214-0#61#76#diseaseC0600139 associated_with COX-2,prostate cancer
25#30#gene451361#76#diseaseC0376358 16506214-0#25#30#gene4513 16506214-0#61#76#diseaseC0376358 associated_with COX-2,prostate cancer
25#30#gene451361#76#diseaseC0600139 16506214-0#25#30#gene4513 16506214-0#61#76#diseaseC0600139 associated_with COX-2,prostate cancer
25#30#gene574361#76#diseaseC0376358 16506214-0#25#30#gene5743 16506214-0#61#76#diseaseC0376358 associated_with COX-2,prostate cancer
25#30#gene574361#76#diseaseC0600139 16506214-0#25#30#gene5743 16506214-0#61#76#diseaseC0600139 associated_with COX-2,prostate cancer
25#30#gene574361#76#diseaseC0376358 16506214-0#25#30#gene5743 16506214-0#61#76#diseaseC0376358 associated_with COX-2,prostate cancer
25#30#gene574361#76#diseaseC0600139 16506214-0#25#30#gene5743 16506214-0#61#76#diseaseC0600139 associated_with COX-2,prostate cancer
131#136#gene451377#91#diseaseC0596263 16506214-10#131#136#gene4513 16506214-10#77#91#diseaseC0596263 associated_with COX-2,carcinogenesis
131#136#gene574377#91#diseaseC0596263 16506214-10#131#136#gene5743 16506214-10#77#91#diseaseC0596263 associated_with COX-2,carcinogenesis
31#36#gene451370#74#diseaseC0030193 16506214-2#31#36#gene4513 16506214-2#70#74#diseaseC0030193 associated_with COX-2,pain
31#36#gene574370#74#diseaseC0030193 16506214-2#31#36#gene5743 16506214-2#70#74#diseaseC0030193 associated_with COX-2,pain

tmVarCorpus

Id Subject Object Predicate Lexical cue
T1 1163-1172 DNAMutation:c|SUB|T|+3100|G denotes +3100 T/G
T2 1177-1186 DNAMutation:c|SUB|C|+8365|T denotes +8365 C/T
T3 1354-1363 DNAMutation:c|SUB|T|+3100|G denotes +3100 T/G
T4 1368-1377 DNAMutation:c|SUB|C|+8365|T denotes +8365 C/T

DisGeNET

Id Subject Object Predicate Lexical cue
T0 1661-1666 gene:4513 denotes COX-2
T1 1607-1621 disease:C0596263 denotes carcinogenesis
T2 1661-1666 gene:5743 denotes COX-2
T3 1607-1621 disease:C0596263 denotes carcinogenesis
T4 1661-1666 gene:4513 denotes COX-2
T5 1694-1709 disease:C0376358 denotes prostate cancer
T6 1661-1666 gene:4513 denotes COX-2
T7 1694-1709 disease:C0600139 denotes prostate cancer
T8 1661-1666 gene:5743 denotes COX-2
T9 1694-1709 disease:C0376358 denotes prostate cancer
T10 1661-1666 gene:5743 denotes COX-2
T11 1694-1709 disease:C0600139 denotes prostate cancer
R1 T0 T1 associated_with COX-2,carcinogenesis
R2 T2 T3 associated_with COX-2,carcinogenesis
R3 T4 T5 associated_with COX-2,prostate cancer
R4 T6 T7 associated_with COX-2,prostate cancer
R5 T8 T9 associated_with COX-2,prostate cancer
R6 T10 T11 associated_with COX-2,prostate cancer